EIGR

Eiger BioPharmaceuticals, Inc.
EIGR

Overview Fund Activity
Delisted

EIGR was delisted on the 10th of April, 2024.

Back to rankings

91 hedge funds and large institutions have $188M invested in Eiger BioPharmaceuticals, Inc. in 2022 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 35 increasing their positions, 24 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
91
Holders Change
-3
Holders Change %
-3.19%
% of All Funds
1.54%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.1%
New
12
Increased
35
Reduced
24
Closed
13
Calls
$666K
Puts
$1K
Net Calls
+$665K
Net Calls Change
-$1.74M

Top Buyers

1
6CM
1
683 Capital Management
New York
$24.4M
2
BlackRock
2
BlackRock
New York
$17.4M
3
UOC
3
UBS O'Connor
Illinois
$1.92M
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$12.1M
5
CA
5
CHI Advisors
New York
$1.2M

Top Sellers

1
VA
1
VR Adviser
New York
$0
2
Adage Capital Partners
2
Adage Capital Partners
Massachusetts
$6.62M
3
Morgan Stanley
3
Morgan Stanley
New York
$5.65M
4
State of Wisconsin Investment Board
4
State of Wisconsin Investment Board
Wisconsin
$0
5
D.E. Shaw & Co
5
D.E. Shaw & Co
New York
$1.62M
Name Holding Trade Value Shares
Change 		Shares
Change %
VC
101
Vivo Capital
California
– -$35K -139 Closed
ACM
102
Aquatic Capital Management
Illinois
– -$5K -20 Closed
PHK
103
Point72 Hong Kong
Hong Kong
– -$3K -11 Closed
1 2 3 4
5